Progressive MS research

People often ask why there aren’t more treatments and therapies for people with progressive forms of MS.

In the past, scientists simply haven’t gained the same understanding of what’s behind progressive MS as they have with relapsing remitting MS. Also, the technology hasn’t been advanced enough to do the kind of research needed to find the right treatments.

This can be very frustrating for people living with primary and secondary progressive MS. 

At the MS Society, we want to change this. We’re investing in dedicated research to try and find treatments and therapies that could benefit people with all types of MS, including people with progressive MS.

Our projects

Here are some of the projects we currently fund aimed at making a difference to people affected by progressive MS. 

• Neuroprotective strategies: Amiloride Clinical Trial in Optic Neuritis (ACTION) 
• Investigating new ways to repair myelin 
• Are infections related to disability progression in people with MS? (Phase II) 
• Managing nocturia in progressive MS 
• The development of a telephone based therapy for people affected by primary and secondary progressive MS 
• CUPID: Cannabinoids to slow disability progression in MS
• MS Society Cambridge Centre for Myelin Repair
• MS Society Edinburgh Centre for Translational Research
• How do mesenchymal stem cells from people with secondary progressive MS differ?
• Identifying neuroprotective treatments for people with MS
• MS Society Tissue Bank
• Can the body’s own stem cells be stimulated to make myelin?